Podrobno

The role of cytokines and chemokines as biomarkers of disease activity in idiopathic nephrotic syndrome in children
ID Kopač, Matjaž (Avtor), ID Jerin, Aleš (Avtor), ID Petrera, Agnese (Avtor), ID Osredkar, Joško (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (528,58 KB)
MD5: 8D56BD17135645C24D32A5FAD3CBA857
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1467-3045/47/2/77 Povezava se odpre v novem oknu

Izvleček
This study investigates the association of plasma concentrations of various cytokines and chemokines with the disease activity of idiopathic nephrotic syndrome (INS) in children in Slovenia. (2) In a prospective single-center study lasting 18 months, we took sequential plasma samples from children with INS at disease onset or relapse (prior to corticosteroid (CS) therapy), at remission, and after discontinuation of CS therapy. The Olink®Target 48 Cytokine Panel was applied to analyze 45 analytes in the plasma samples, adhering to the manufacturer’s protocol. We performed a statistical analysis with a paired samples analysis with a t-test as well as with a non-parametric Wilcoxon correction test. (3) We included 18 pediatric patients with INS in the study. We demonstrated statistically significant differences in the concentrations of CSF1, IL4, FLT3LG, CCL19, and MMP12 in the patients at disease onset or relapse compared to those in remission, differences in the concentrations of CSF1 and IL17F in the patients at disease onset or relapse compared to those in remission after CS treatment, and differences in the concentrations of CCL19, MMP12, and CCL13 in the patients in remission compared to those in remission after CS treatment. (4) The findings support potential roles of certain cytokines and chemokines, especially CSF1, CCL19, and MMP12, in influencing the disease activity of INS.

Jezik:Angleški jezik
Ključne besede:cytokines, chemokines, idiopathic nephrotic syndrome, children
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:11 str.
Številčenje:Vol. 47, iss. 2, [article no.] 7
PID:20.500.12556/RUL-167044 Povezava se odpre v novem oknu
UDK:61:616.611-053.2
ISSN pri članku:1467-3045
DOI:10.3390/cimb47020077 Povezava se odpre v novem oknu
COBISS.SI-ID:224866819 Povezava se odpre v novem oknu
Datum objave v RUL:05.02.2025
Število ogledov:422
Število prenosov:101
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Current issues in molecular biology
Skrajšan naslov:Curr. issues mol. biol.
Založnik:MDPI
ISSN:1467-3045
COBISS.SI-ID:521769497 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:kemokini, idiopatski nefrotski sindrom, otroci, citokini, nefrotski sindrom

Projekti

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:20220062
Naslov:University Medical Center, tertiary science project

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj